ArticleArthroscopy, sports medicine, and rehabilitation2026
Indices of Systemic Inflammation Are Elevated in Women With Evidence of Metabolic Syndrome After Anterior Cruciate Ligament Reconstruction.
Article in Arthroscopy, sports medicine, and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate the association between metabolic syndrome (MetSy) and systemic indices of the immune system and inflammation after anterior cruciate ligament reconstruction (ACLR). Methods: This retrospective study included adult patients (≥18 years) who underwent ACLR at a single academic institution between 2009 and 2022. Patients with documented complete blood cell count ≥90 days postoperatively and complete MetSy component data were included. From complete blood cell data, the pan-immune-inflammation value (PIV), systemic inflammation response index (SIRI), systemic immune-inflammatory index (SII), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio were calculated. Evidence of MetSy was defined by ≥3 of the following: body mass index ≥30, triglycerides ≥150 mg/dL, high-density lipoprotein < 40 mg/dL (men) or <50 mg/dL (women), estimated fasting glucose ≥ 100 mg/dL, and systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg. Patients (n = 130) were grouped based on MetSy status at ACLR: MetSy or non-MetSy. Results: A total of 130 patients were included: 50 MetSy and 80 non-MetSy. The NLR, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, SIRI, SII, and PIV did not differ significantly between MetSy groups. However, NLR, platelet-to-lymphocyte ratio, SII, and PIV were significantly elevated ( Conclusions: Indices of systemic inflammation after ACLR were elevated in women with evidence of MetSy. Patients with postoperative complications also exhibited an elevation in systemic indices of inflammation after ACLR. Level of Evidence: Level III, retrospective comparative study.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.